Cargando…

The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study

Background: Individuals with 22q11.2 deletion syndrome (22q11DS) are at increased risk of developing psychosis and cognitive impairments, which may be related to dopaminergic and glutamatergic abnormalities. Therefore, in this exploratory study, we examined the association between dopaminergic and g...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hooijdonk, Carmen F. M., Tse, Desmond H. Y., Roosenschoon, Julia, Ceccarini, Jenny, Booij, Jan, van Amelsvoort, Therese A. M. J., Vingerhoets, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498700/ https://www.ncbi.nlm.nih.gov/pubmed/36140839 http://dx.doi.org/10.3390/genes13091672

Ejemplares similares

Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study
por: Vingerhoets, Claudia, et al.
Publicado: (2020)

Lower [(18)F]fallypride binding to dopamine D(2/3) receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study
por: van Duin, Esther D. A., et al.
Publicado: (2020)

T173. GABA AND GLUTAMATE IN PATIENTS WITH 22Q11.2 DELETION SYNDROME AND HEALTHY VOLUNTEERS AND THE RELATION WITH COGNITION: A RANDOMIZED DOUBLE-BLIND 7TESLA PHARMACOLOGICAL MRS STUDY
por: Vingerhoets, Claudia, et al.
Publicado: (2018)

Post-traumatic stress in adults with 22q11.2 deletion syndrome
por: von Scheibler, Emma N. M. M., et al.
Publicado: (2022)

Cognitive deficits in childhood, adolescence and adulthood in 22q11.2 deletion syndrome and association with psychopathology
por: Morrison, Sinead, et al.
Publicado: (2020)

Adverse effects of antipsychotic medication in patients with 22q11.2 deletion syndrome: A systematic review
por: de Boer, Janna, et al.
Publicado: (2019)

Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome
por: Shin, Woosub, et al.
Publicado: (2023)

Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome
por: Evers, Laurens J. M., et al.
Publicado: (2015)

Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome
por: Bakker, Geor, et al.
Publicado: (2016)

Dopaminergic neurons in chromosome 22q11.2 deletion syndrome
por: Inoue, Haruhisa
Publicado: (2021)

Environmental Influences on the Relation between the 22q11.2 Deletion Syndrome and Mental Health: A Literature Review
por: Snihirova, Yelyzaveta, et al.
Publicado: (2022)

COMT Val(158)Met Genotype Selectively Alters Prefrontal [(18)F]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge
por: Hernaus, Dennis, et al.
Publicado: (2013)

Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
por: Arioka, Yuko, et al.
Publicado: (2020)

Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: (18)F-Fallypride Positron Emission Tomography Study
por: Kuepper, Rebecca, et al.
Publicado: (2013)

Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study
por: Modinos, G, et al.
Publicado: (2017)

Multi-GBq production of the radiotracer [(18)F]fallypride in a droplet microreactor
por: Wang, Jia, et al.
Publicado: (2020)

F144. MUSCARINIC M1 RECEPTOR SIGNALLING UNDERLYING COGNITION IN PSYCHOTIC DISORDERS
por: van Amelsvoort, Therese, et al.
Publicado: (2018)

Risk of malignancy in 22q11.2 deletion syndrome
por: Stevens, Toer, et al.
Publicado: (2017)

Relationship between muscarinic M(1) receptor binding and cognition in medication-free subjects with psychosis()
por: Bakker, Geor, et al.
Publicado: (2018)

Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study
por: von Scheibler, Emma N. M. M., et al.
Publicado: (2021)

The Genetics and Epigenetics of 22q11.2 Deletion Syndrome
por: Du, Qiumei, et al.
Publicado: (2020)

S172. BRAIN METABOLITES AND THE RELATION WITH COGNITION AND PSYCHOTIC SYMPTOMS IN MEDICATION-FREE PSYCHOSIS AND CONTROLS: A PHARMACOLOGICAL MAGNETIC RESONANCE SPECTROSCOPY STUDY
por: Vingerhoets, Claudia, et al.
Publicado: (2018)

Adult Height, 22q11.2 Deletion Extent, and Short Stature in 22q11.2 Deletion Syndrome
por: Heung, Tracy, et al.
Publicado: (2022)

Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study
por: Rogdaki, Maria, et al.
Publicado: (2021)

Psychopathology and cognition in children with 22q11.2 deletion syndrome
por: Niarchou, Maria, et al.
Publicado: (2014)

Otologic and audiologic findings in 22q11.2 deletion syndrome
por: Verheij, E., et al.
Publicado: (2016)

[(18)F]fallypride characterization of striatal and extrastriatal D(2/3) receptors in Parkinson's disease
por: Stark, Adam J., et al.
Publicado: (2018)

Platybasia in 22q11.2 Deletion Syndrome Is Not Correlated with Speech Resonance
por: Spruijt, Nicole E, et al.
Publicado: (2014)

T165. ANTI-GLUTAMATERGIC PROPERTY OF N-ACETYLCYSTEINE DOCUMENTED IN VIVO WITH 1H MRS
por: Shungu, Dikoma, et al.
Publicado: (2020)

Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
por: Cleynen, Isabelle, et al.
Publicado: (2020)

Subcortical Myoclonus and Associated Dystonia in 22q11.2 Deletion Syndrome
por: Van Iseghem, Vincent, et al.
Publicado: (2020)

Affective and psychotic reactivity to daily-life stress in adults with 22q11DS: a study using the experience sampling method
por: Schneider, Maude, et al.
Publicado: (2020)

Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size
por: Sun, Daqiang, et al.
Publicado: (2018)

Hematological abnormalities and 22q11.2 deletion syndrome
por: Rosa, Rafael Fabiano Machado, et al.
Publicado: (2011)

Obesity in adults with 22q11.2 deletion syndrome
por: Voll, S, et al.
Publicado: (2016)

Complement Activation in 22q11.2 Deletion Syndrome
por: Grinde, Dina, et al.
Publicado: (2020)

Laryngeal web with 22q11.2 deletion syndrome
por: Abe, Yasuhiro, et al.
Publicado: (2022)

Tonsillectomy in Children with 22q11.2 Deletion Syndrome
por: Arganbright, Jill M., et al.
Publicado: (2022)

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
por: Gasiorowska, Anna, et al.
Publicado: (2021)

The internet is parents' main source of information about psychiatric manifestations of 22q11.2 deletion syndrome (22q11.2DS)()
por: van den Bree, Marianne B.M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j21001sqmsbe4l2ve26cikjo82